CClinicalTrials.gg
CompletedNCT02932657MUCO-ART-PLUSUpdated Jan 30, 2019

Perceived Impact of Art Therapy in Patients With Cystic Fibrosis and in Professional Interdisciplinary Teams Taking Care of Them.

An observational study in Cystic Fibrosis, sponsored by Nantes University Hospital. Completed at 2 sites in France. Open to participants aged 13 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-30.

Sponsored by Nantes University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
23
Ages
13 Years and older
Sex
All
01

Study summary

Cystic fibrosis is so far a disease whose treatment remains essentially symptomatic care teams perceive the boundaries of a support mainly focused on drug treatments. The patient had no other choice but to learn to live with their disease, the goal is to make every effort so that tames the disease while maintaining high self-esteem that gives meaning to his life, allowing, among other things, a good grip of treatment.

Through this research we hope to encourage the integration of art therapy in the course of care of cystic fibrosis patients, from children to adults before and after transplantation, in connection with the patient education and counseling

02

Conditions studied

  • Cystic Fibrosis
03

In context

Cystic Fibrosis

1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.

This study's enrollment of 23 is below the median of 85 across 482 observational studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Will be included in this research project:

  • Adolescents aged 13 to 18, followed by the cystic fibrosis Children center of Nantes that have benefited from art therapy session
  • Non transplanted adult patients followed cystic fibrosis center of Foch and having already benefited from art therapy session
  • The transplanted adult patients followed the transplantation center Foch and having already benefited from art therapy session

Eligibility criteria

Inclusion Criteria:

  • Cystic fibrosis aged adolescents 13 to 18 years, as part of their monitoring at cystic fibrosis center of Nantes
  • Adults over 18 years nontransplanted in their follow at cystic fibrosis center/transplantation center of Foch
  • More than 18 adult transplant as part of their monitoring at cystic fibrosis center/transplantation center Foch
  • Professional interdisciplinary teams taking care of the cystic fibrosis children center of Nantes, cystic fibrosis center/transplantation center of Foch
  • Agreeing to participate in research

Non Inclusion Criteria:

  • Patient refusal of adolescent parents to participate in the study
  • Professional refusal of teams to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
23 participants (actual)
Patient registry
No

Interventions

  • OtherNon interventional study

    First individual interviews will be set up with teenagers of Nantes University Hospital . Then, focus group will be conduct with patients and professionals in Nantes and Foch University Hospital.

06

What researchers measure

Primary outcomes

  1. Patient responses to the effects of art therapy and music therapy

    The depth interviews with patients will achieve a thematic and structural analysis of the speech. This will capture the effects of art therapy and music therapy on patients, their point of view.

    Time frame: 1 day

07

Study locations

2 sites
  • Nantes University Hospital
    Nantes, 44093, France
  • Foch Hospital
    Suresnes, 92151, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02932657
Lead sponsor
Nantes University Hospital
Responsible party
Sponsor
First posted
Oct 13, 2016
Start date
Jun 29, 2017
Primary completion
Jan 28, 2018
Completion
Jan 28, 2018
Last update
Jan 30, 2019

Study contacts

Valérie David, Dr
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion